Bionano Genomics, Inc. BNGOW 深 滬
等待開盤 08-18 09:30:00 美东时间
0.0036
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0036
- 總市值 100.37万
- 52周最高 0.604
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.0019
- 委 比 0.00%
- 總股本 2.79亿
- 歷史最高 11.82
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.0019
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bionano Genomics Q2 EPS $(1.99) Beats $(2.42) Estimate, Sales $6.733M Miss $6.832M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.42) by 17.6 percent. This is a 86.18 percent increase over losses of $(14.40) per share from
08-15 04:34
Bionano Genomics Sees Q3 Sales $6.700M-$7.200M vs $7.661M Est
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.
08-15 04:04
A Preview Of Bionano Genomics's Earnings
Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings rep...
08-14 02:02
Maxim Group Upgrades Bionano Genomics to Buy, Announces $8 Price Target
Maxim Group analyst Jason McCarthy upgrades Bionano Genomics (NASDAQ:BNGO) from Hold to Buy and announces $8 price target.
05-20 22:39
Bionano Genomics Lowers FY2025 Sales Guidance from $29.00M-$32.00M to $26.00M-$30.00M vs $33.43M Est
Bionano Genomics (NASDAQ:BNGO) lowers FY2025 sales outlook from $29.00 million-$32.00 million to $26.00 million-$30.00 million vs $33.43 million estimate.
05-15 05:22
Bionano Genomics stock rises on Q1 revenue beat
Bionano Genomics (NASDAQ:BNGO) shares jumped in post market trading on Wednesday after it reported its first quarter revenue above expectations. The company posted first quarter revenue of $6.46M, bea...
05-15 05:02
Bionano Genomics shares are trading higher following better-than-expected Q1 reported financial results.
Bionano Genomics shares are trading higher following better-than-expected Q1 re...
05-15 04:22
Bionano Genomics Q1 Sales $6.50M Beat $6.23M Estimate
Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.23 million by 4.28 percent. This is a 25.88 percent decrease over sales of $8.77 million the same
05-15 04:02
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
A Glimpse of Bionano Genomics's Earnings Potential
Bionano Genomics (NASDAQ:BNGO) is preparing to release its quarterly earnings o...
05-14 03:03
